This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Mitsubishi Pharma Corporation, Mitsubishi Tanabe Pharma Corporation. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2009-2012
Title: The Innovations of Setsuo Yamashita
Introduction
Setsuo Yamashita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active substances. With a total of 2 patents, his work has had a considerable impact on therapeutic applications.
Latest Patents
Yamashita's latest patents include the invention of an enantiomer of tenatoprazole and its use in therapy. This invention relates to optically active substances of tenatoprazole, specifically the compounds (+) and (−)-5-methoxy-2-{(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl}-1H-imidazo[4,5-b]pyridine. These compounds and their pharmaceutical compositions are recognized for their utility as anti-ulcer agents.
Career Highlights
Throughout his career, Setsuo Yamashita has worked with prominent companies in the pharmaceutical industry. He has been associated with Mitsubishi Pharma Corporation and Mitsubishi Tanabe Pharma Corporation, where he has contributed to various innovative projects.
Collaborations
Yamashita has collaborated with several professionals in his field, including Kengo Ebina. Their joint efforts have further advanced the research and development of pharmaceutical innovations.
Conclusion
Setsuo Yamashita's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence therapeutic practices and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile